Founded in Taiwan in 1988, it is a well-known high-end physical examination brand in China, and is affiliated to Meinian Health Group, providing high-quality/high-efficiency new ways of health management and personalized health management solutions
MJ brand began in Kaohsiung, Taiwan in 1988 and has a history of 30 years.
Among them, the four high-end health examination centers in Taiwan have been the earliest for 29 years, Hong Kong for 18 years, Malaysia for 11 years, Beijing for 15 years, and Shanghai for 9 years.
MJ brand is a health manager of innovative medical care, ranking among the world's top three health management institutions along with BUPA in the United Kingdom and PL in Japan, focusing on providing high-quality and efficient new ways of health management for social elites. MJ Health is committed to improving the quality of life for customers, establishing effective health management plans, and providing personalized health management solutions, using advanced health examination services and technology to serve global, individual, family and group customers.
MJ brand is also the first health management center in the world to obtain ISO9001 international quality certification, and its automated health examination system, advanced testing equipment, and the world's most advanced testing equipment are all world-class professional standards. In the future, it will become one of the largest international health care institutions in the world.
Founded in 2004, Meinian Health Industry (Group) Co., Ltd. is a leading professional health examination and medical service group in China, with more than 200 medical and physical examination centers in 29 provinces and cities across the country, headquartered in Shanghai, deeply engaged in more than 70 core cities such as Beijing, Shenzhen, Shenyang, Guangzhou, Chengdu, Wuhan, Xi'an, Tianjin, Chongqing, Hangzhou, etc., with a full-time expert, medical and management team of 20,000 people, and providing professional health services for nearly 10 million people in 2015. The Group was successfully listed on the A-share market (SZ:002044) in 2015 and is a listed company with the leading market capitalization and influence in the medical and health sectors.
